tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

AbbVie small cell lung cancer treatment granted FDA orphan designation

AbbVie (ABBV) was granted FDA orphan designation for an antibody drug conjugate comprising monoclonal antibody anti-SEZ6 IgG1 antibody conjugated to a Top1 inhibitor as a treatment of small cell lung cancer, according to a post to the FDA website.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1